Patents by Inventor Patrick J. Phillips
Patrick J. Phillips has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12076251Abstract: Bone implants, including methods of use and assembly. The bone implants, which are optionally composite implants, generally include a distal anchoring region and a growth region that is proximal to the distal anchoring region. The distal anchoring region can have one or more distal surface features that adapt the distal anchoring region for anchoring into iliac bone. The growth region can have one or more growth features that adapt the growth region to facilitate at least one of bony on-growth, in-growth, or through-growth. The implants may be positioned along a posterior sacral alar-iliac (“SAI”) trajectory. The implants may be coupled to one or more bone stabilizing constructs, such as rod elements thereof.Type: GrantFiled: January 28, 2022Date of Patent: September 3, 2024Assignee: SI-Bone Inc.Inventors: Ali H. Mesiwala, Mark A. Reiley, Paul M. Sand, Bret W. Schneider, Scott A. Yerby, Christopher I. Shaffrey, Robert K. Eastlack, Juan S. Uribe, Isador H. Lieberman, Frank M. Phillips, David W. Polly, Phillip J. Singer, Jeffrey B. Phelps, Derek P. Lindsey, Patrick Kahn, Nikolas F. Kerr, Francois Follini
-
Publication number: 20240287061Abstract: The present disclosure relates generally to certain 6-azabenzimidazole compounds, pharmaceutical compositions comprising said compounds, and methods of making and using said compounds and pharmaceutical compositions. The compounds and compositions disclosed herein may be used for the treatment or prevention of diseases, disorders, or infections modifiable by hematopoietic progenitor kinase 1 (HPK1) inhibitors, such as HBV, HIV, cancer, and/or a hyper-proliferative disease.Type: ApplicationFiled: December 18, 2023Publication date: August 29, 2024Inventors: Gayatri Balan, Mark J. Bartlett, Jayaraman Chandrasekhar, Julian A. Codelli, John H. Conway, Jennifer L. Cosman Ellis, Rao V. Kalla, Zachary A. Kasun, Musong Kim, Seung H. Lee, Jennifer R. Lo, Jennifer A. Loyer-Drew, Scott A. Mitchell, Thao D. Perry, Gary B. Phillips, Patrick J. Salvo, Sundaramoorthi Swaminathan, Joshua J. Van Veldhuizen, Suet C. Yeung, Jeff Zablocki
-
Patent number: 11247076Abstract: Apparatus and methods for creating tissue necrosis include an energy delivery apparatus that can be positioned adjacent a target treatment site such as a vessel without direct contact with the treatment site tissue. Collimated energy is then directed to the vessel to create necrotic regions in the tissue. Exemplary use in renal vessels creates necrotic regions in adjacent nerves which can alleviate hypertension in a patient.Type: GrantFiled: March 28, 2019Date of Patent: February 15, 2022Assignee: Auris Health, Inc.Inventors: Michael J. Pederson, Patrick J. Phillips, John P. Madden, Michael J. Horzewski
-
Publication number: 20190232092Abstract: Apparatus and methods for creating tissue necrosis include an energy delivery apparatus that can be positioned adjacent a target treatment site such as a vessel without direct contact with the treatment site tissue. Collimated energy is then directed to the vessel to create necrotic regions in the tissue. Exemplary use in renal vessels creates necrotic regions in adjacent nerves which can alleviate hypertension in a patient.Type: ApplicationFiled: March 28, 2019Publication date: August 1, 2019Inventors: Michael J. PEDERSON, Patrick J. PHILLIPS, John P. MADDEN, Michael J. HORZEWSKI
-
Patent number: 10286231Abstract: Apparatus and methods for creating tissue necrosis include an energy delivery apparatus that can be positioned adjacent a target treatment site such as a vessel without direct contact with the treatment site tissue. Collimated energy is then directed to the vessel to create necrotic regions in the tissue. Exemplary use in renal vessels creates necrotic regions in adjacent nerves which can alleviate hypertension in a patient.Type: GrantFiled: January 30, 2013Date of Patent: May 14, 2019Assignee: VytronUS, Inc.Inventors: Michael J. Pederson, Patrick J. Phillips, John P. Madden, Michael J. Horzewski
-
Publication number: 20140046313Abstract: Apparatus and methods for creating tissue necrosis include an energy delivery apparatus that can be positioned adjacent a target treatment site such as a vessel without direct contact with the treatment site tissue. Collimated energy is then directed to the vessel to create necrotic regions in the tissue. Exemplary use in renal vessels creates necrotic regions in adjacent nerves which can alleviate hypertension in a patient.Type: ApplicationFiled: January 30, 2013Publication date: February 13, 2014Applicant: VytronUS, Inc.Inventors: Michael J. Pederson, Patrick J. Phillips, John P. Madden, Michael J. Horzewski
-
Patent number: 8491483Abstract: Highly specific measurements of flow in vessels, such as the coronary artery, can be obtained by processing cubic fundamental information. By showing flow in vessels with a high degree of contrast-to-tissue specificity, ultrasound based 3D contrast agent based coronary artery angiograms may be possible. Measurement and display of the velocity of agent from the cubic fundamental signal is provided simultaneously with display of cubic fundamental energy, such as providing a display map indexed by both energy and velocity. High pulse repetition frequency (PRF) for cubic fundamental detection in conjunction with long velocity measurement intervals may increase low velocity sensitivity and measurement precision. Pulsed wave (PW) Doppler may be improved by using a cubic fundamental sensitive pulse sequence.Type: GrantFiled: September 19, 2008Date of Patent: July 23, 2013Assignee: Siemens Medical Solutions USA, Inc.Inventors: Ismayil M. Guracar, James E. Chomas, Patrick J. Phillips
-
Patent number: 8177719Abstract: Highly specific measurements of flow in vessels, such as the coronary artery, can be obtained by processing cubic fundamental information. By showing flow in vessels with a high degree of contrast-to-tissue specificity, ultrasound based 3D contrast agent based coronary artery angiograms may be possible. Measurement and display of the velocity of agent from the cubic fundamental signal is provided simultaneously with display of cubic fundamental energy, such as providing a display map indexed by both energy and velocity. High pulse repetition frequency (PRF) for cubic fundamental detection in conjunction with long velocity measurement intervals may increase low velocity sensitivity and measurement precision. Pulsed wave (PW) Doppler may be improved by using a cubic fundamental sensitive pulse sequence.Type: GrantFiled: June 14, 2005Date of Patent: May 15, 2012Assignee: Siemens Medical Solutions USA, Inc.Inventors: Ismayil M. Guracar, James E. Chomas, Patrick J. Phillips
-
Patent number: 7998076Abstract: Contrast agents are characterized with ultrasound. Flowing or unbound contrast agents are distinguished automatically from bound or relatively stationary contrast agents. The bound or relatively stationary contrast agents are highlighted on a display. A processor distinguishes different types of contrast agents or contrast agents in different binding states with relative signal strength or velocity. Attached contrast agents are differentiated from phagocytosed contrast agents. Monitoring absolute signal strength as a function of time may indicate binding. Any one or more of these features may be used.Type: GrantFiled: September 27, 2005Date of Patent: August 16, 2011Assignee: Siemens Medical Solutions USA, Inc.Inventors: Patrick J. Phillips, James E. Chomas, Ismayil M. Guracar
-
Patent number: 7993273Abstract: System parameters for contrast agent medical imaging are conveniently set. A simplified contrast agent configuration is provided where an appropriate contrast agent detection technique and/or contrast agent imaging parameters are achieved consistently and more often then exists with current methods. Examination workflow is improved for contrast agent studies by offering one contrast agent imaging mode or configuration that is dynamically determined and optimized based on the user's selected transmit level and/or a real-time measurement of the contrast agent signals. A simplified user interface provides one contrast agent imaging mode without a need to switch between multiple modes or contrast agent detection techniques and associated contrast agent imaging parameters. The contrast agent detection technique and imaging parameters are adjusting or selected based on changes in the transmit levels for contrast agent imaging.Type: GrantFiled: May 29, 2008Date of Patent: August 9, 2011Assignee: Siemens Medical Solutions USA, Inc.Inventors: Patrick J. Phillips, Ismayil M. Guracar
-
Patent number: 7946990Abstract: A method is provided to improve the frame-rate in color-flow ultrasound imaging using simultaneous spatially-distinct transmit beams with one or more frequency bands per transmit beam. Pulses of different center frequencies are used simultaneously in different (lateral and/or elevational) directions, thereby reducing the scanning time and improving the frame-rates. Optionally, a multi-modal pulse is used, and flow is estimated separately for the different frequencies. The flow estimates for these pulses are appropriately combined to improve low-velocity sensitivity and to reduce aliasing. A flow sample count with two or more different pulse repetition intervals can be used to further improve low-flow sensitivity and minimize aliasing.Type: GrantFiled: September 30, 2005Date of Patent: May 24, 2011Assignee: Siemens Medical Solutions USA, Inc.Inventors: Seshadri Srinivasan, Patrick J. Phillips, Charles E. Bradley
-
Patent number: 7887484Abstract: Velocity scale is automatically determined for ultrasound imaging. Receive signals corresponding to different pulse repetition intervals are used to estimate velocities. The different velocities are used to determine the velocity scale. For example, the different pulse repetition intervals are obtained by selecting different sets of signals from a group of signals for a scan line. As another example, the different pulse repetition intervals are obtained by transmitting for a scan line with changing, such as increasing, pulse repetition intervals. The lower pulse repetition interval of a pair of intervals associated with a sign change in the phase is used for the velocity scale. In yet another example, at least two demodulation frequencies are used for a broadband transmit in at least two sets, each set with a different pulse repetition interval. Velocities are estimated for a greater number of pulse repetition intervals than transmitted using the broadband pulses.Type: GrantFiled: August 12, 2005Date of Patent: February 15, 2011Assignee: Siemens Medical Solutions USA, Inc.Inventors: Seshadri Srinivasan, Bhaskar Ramamurthy, Ismayil M. Guracar, Patrick J. Phillips, Rickard C. Loftman
-
Patent number: 7837626Abstract: Contrast agents are manipulated with acoustic radiation force while ultrasound imaging. Continuous waves for acoustic radiation force are transmitted. Substantially simultaneously, pulsed waves for imaging are transmitted. Low mechanical index continuous and pulsed waves may be used to increase binding efficiency of drug containing contrast agents with the tissue for treatment. Various techniques may be used to minimize the effect of the continuous waves on imaging with the pulsed waves. The acoustic radiation force may be transmitted with an amplitude profile and/or unfocused or defocused.Type: GrantFiled: August 5, 2005Date of Patent: November 23, 2010Assignee: Siemens Medical Solutions USA, Inc.Inventors: James E. Chomas, Ismayil M. Guracar, Patrick J. Phillips, John D. Marshall
-
Patent number: 7775981Abstract: A transmit sequence for contrast agent imaging that improves sensitivity and minimizes image artifacts. The number of pulses and the interleaving of spatially distinct pulses between spatially co-linear pulses are selected such that a substantially similar pulse sequence for substantially each line in a scanned region is generated. A collateral pulse from a different scan line is interleaved between at least two imaging pulses along a scan line of interest. Such pulse sequences provide sensitive contrast agent imaging with minimized spatial variation. In another aspect, responsive signals representing the first and second scan lines are obtained. Intensities associated with the signals are determined. The intensities associated with the first scan line are compared to a value.Type: GrantFiled: September 6, 2000Date of Patent: August 17, 2010Assignee: Siemens Medical Solutions USA, Inc.Inventors: Ismayil M. Guracar, Patrick J. Phillips
-
Patent number: 7591788Abstract: System parameters for contrast agent medical imaging are conveniently set. A simplified contrast agent configuration is provided. One contrast agent imaging mode or configuration is dynamically determined and optimized based on the user's selected transmit level and/or a real-time measurement of the contrast agent signals. A simplified user interface provides one contrast agent imaging mode without a need to switch between multiple modes or contrast agent detection techniques and associated contrast agent imaging parameters. The contrast agent detection technique and imaging parameters are adjusted or selected based on changes in the transmit levels for contrast agent imaging. Appropriate contrast agent detection techniques and imaging parameters are selected for each given transmit level without the user having to switch the mode or configuration of the system during an imaging session.Type: GrantFiled: August 19, 2003Date of Patent: September 22, 2009Assignee: Siemens Medical Solutions USA, Inc.Inventors: Patrick J. Phillips, Ismayil Guracar
-
Publication number: 20090082672Abstract: Highly specific measurements of flow in vessels, such as the coronary artery, can be obtained by processing cubic fundamental information. By showing flow in vessels with a high degree of contrast-to-tissue specificity, ultrasound based 3D contrast agent based coronary artery angiograms may be possible. Measurement and display of the velocity of agent from the cubic fundamental signal is provided simultaneously with display of cubic fundamental energy, such as providing a display map indexed by both energy and velocity. High pulse repetition frequency (PRF) for cubic fundamental detection in conjunction with long velocity measurement intervals may increase low velocity sensitivity and measurement precision. Pulsed wave (PW) Doppler may be improved by using a cubic fundamental sensitive pulse sequence.Type: ApplicationFiled: September 19, 2008Publication date: March 26, 2009Inventors: Ismayil M. Guracar, James E. Chomas, Patrick J. Phillips
-
Publication number: 20090082671Abstract: Highly specific measurements of flow in vessels, such as the coronary artery, can be obtained by processing cubic fundamental information. By showing flow in vessels with a high degree of contrast-to-tissue specificity, ultrasound based 3D contrast agent based coronary artery angiograms may be possible. Measurement and display of the velocity of agent from the cubic fundamental signal is provided simultaneously with display of cubic fundamental energy, such as providing a display map indexed by both energy and velocity. High pulse repetition frequency (PRF) for cubic fundamental detection in conjunction with long velocity measurement intervals may increase low velocity sensitivity and measurement precision. Pulsed wave (PW) Doppler may be improved by using a cubic fundamental sensitive pulse sequence.Type: ApplicationFiled: September 19, 2008Publication date: March 26, 2009Inventors: Ismayil M. Guracar, James E. Chomas, Patrick J. Phillips
-
Publication number: 20090012400Abstract: Highly specific measurements of flow in vessels, such as the coronary artery, can be obtained by processing cubic fundamental information. By showing flow in vessels with a high degree of contrast-to-tissue specificity, ultrasound based 3D contrast agent based coronary artery angiograms may be possible. Measurement and display of the velocity of agent from the cubic fundamental signal is provided simultaneously with display of cubic fundamental energy, such as providing a display map indexed by both energy and velocity. High pulse repetition frequency (PRF) for cubic fundamental detection in conjunction with long velocity measurement intervals may increase low velocity sensitivity and measurement precision. Pulsed wave (PW) Doppler may be improved by using a cubic fundamental sensitive pulse sequence.Type: ApplicationFiled: September 19, 2008Publication date: January 8, 2009Inventors: Ismayil M. Guracar, James E. Chomas, Patrick J. Phillips
-
Publication number: 20080228070Abstract: System parameters for contrast agent medical imaging are conveniently set. A simplified contrast agent configuration is provided where an appropriate contrast agent detection technique and/or contrast agent imaging parameters are achieved consistently and more often then exists with current methods. Examination workflow is improved for contrast agent studies by offering one contrast agent imaging mode or configuration that is dynamically determined and optimized based on the user's selected transmit level and/or a real-time measurement of the contrast agent signals. A simplified user interface provides one contrast agent imaging mode without a need to switch between multiple modes or contrast agent detection techniques and associated contrast agent imaging parameters. The contrast agent detection technique and imaging parameters are adjusting or selected based on changes in the transmit levels for contrast agent imaging.Type: ApplicationFiled: May 29, 2008Publication date: September 18, 2008Applicant: SIEMENS MEDICAL SOLUTIONS USA, INC.Inventors: Patrick J. Phillips, Ismayil Guracar
-
Patent number: 7004906Abstract: Highly specific measurements of flow in vessels, such as the coronary artery, can be obtained by processing cubic fundamental information. By showing flow in vessels with a high degree of contrast-to-tissue specificity, ultrasound based 3D contrast agent based coronary artery angiograms may be possible. Measurement and display of the velocity of agent from the cubic fundamental signal is provided simultaneously with display of cubic fundamental energy, such as providing a display map indexed by both energy and velocity. High pulse repetition frequency (PRF) for cubic fundamental detection in conjunction with long velocity measurement intervals may increase low velocity sensitivity and measurement precision. Pulsed wave (PW) Doppler may be improved by using a cubic fundamental sensitive pulse sequence.Type: GrantFiled: July 26, 2004Date of Patent: February 28, 2006Assignee: Siemens Medical Solutions USA, Inc.Inventors: Ismayil M. Guracar, James E. Chomas, Patrick J. Phillips